2023 Q1 Report: Global Trends in Biopharma Transactions
2023 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on […]
2023 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on […]
2022 Year In Review Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and
2022 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2022 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends on
2021 Year End Report Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our 2021
Bought Not Sold Why So Many Biopharma M&A Transactions Start Out as Aspirational Licensing Deals Authors: Geoff Meyerson, CEO & Co-Founder
2021 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends on
iPSC Market Overview In this report you can find an overview and analysis of the following across the iPSC market: Summary
2021 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends on
2021 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends on